PCVX Vaxcyte, Inc.
Nasdaq · SEC CIK 1649094 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $9.09M 23 sales by 5 insiders
- Filings on record
- 321 since 2021-07-22, latest 2026-09-09 17:56
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| PICKERING GRANT | CEO, Dir | — | $3.63M |
| GUGGENHIME ANDREW | Pres AND CFO | — | $1.64M |
| Wassil Jim | EVP, COO, Chief Scientific Ofc | — | $1.43M |
| Dhaliwal Harpreet S. | Chief Technical Ops Off | — | $1.39M |
| Cowan Elvia | SVP, Fin | — | $988.6K |
| Jodar Luis | Chief Medical Off | — | — |
| Lee Jacks | Dir | — | — |
| Loxam Teri | Dir | — | — |
| Furey John | Dir | — | — |
| Paya Carlos V | Dir | — | — |
Transactions 469
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-05-20 | 2022-05-18 | PCVX | GUGGENHIME ANDREW | Pres, CFO | S - Sale+OE | $24.44 | -3,100 | 42.8K | -7% | -$75.8K |
| D | 2022-05-20 | 2022-05-18 | PCVX | GUGGENHIME ANDREW | Pres, CFO | M - OptEx | $5.35 | +3,100 | 45.3K | +7% | +$16.6K |
| DM | 2022-05-18 | 2022-05-16 | PCVX | PICKERING GRANT | CEO, Dir | S - Sale+OE | $23.91 | -11.0K | 703.9K | -2% | -$263.0K |
| D | 2022-05-18 | 2022-05-16 | PCVX | PICKERING GRANT | CEO, Dir | M - OptEx | $1.79 | +11.0K | 714.9K | +2% | +$19.7K |
| I | 2022-05-09 | 2022-05-05 | PCVX | Fairman Jeff | VP, Research | S - Sale | $25.80 | -888 | 325.3K | -0.3% | -$22.9K |
| 2022-04-26 | 2022-04-22 | PCVX | Sauer Paul | SVP Process Dev, Manufacturing | S - Sale | $25.00 | -3,000 | 25.1K | -11% | -$75.0K | |
| D | 2022-04-20 | 2022-04-18 | PCVX | Wassil Jim | COO | M - OptEx | $2.42 | +2,800 | 45.7K | +7% | +$6,776 |
| D | 2022-04-20 | 2022-04-18 | PCVX | Wassil Jim | COO | S - Sale+OE | $23.98 | -2,800 | 42.9K | -6% | -$67.1K |
| D | 2022-04-20 | 2022-04-18 | PCVX | PICKERING GRANT | CEO, Dir | M - OptEx | $1.79 | +11.0K | 714.9K | +2% | +$19.7K |
| D | 2022-04-20 | 2022-04-18 | PCVX | PICKERING GRANT | CEO, Dir | S - Sale+OE | $23.98 | -11.0K | 703.9K | -2% | -$263.8K |
| D | 2022-04-20 | 2022-04-18 | PCVX | GUGGENHIME ANDREW | Pres, CFO | M - OptEx | $5.35 | +3,100 | 43.7K | +8% | +$16.6K |
| D | 2022-04-20 | 2022-04-18 | PCVX | GUGGENHIME ANDREW | Pres, CFO | S - Sale+OE | $24.05 | -3,100 | 40.6K | -7% | -$74.6K |
| I | 2022-04-07 | 2022-04-05 | PCVX | Fairman Jeff | VP, Research | S - Sale | $25.59 | -5,000 | 326.2K | -2% | -$128.0K |
| 2022-03-24 | 2022-03-22 | PCVX | Sauer Paul | SVP Process Dev, Manufacturing | S - Sale | $25.00 | -3,000 | 28.1K | -10% | -$75.0K | |
| DM | 2022-03-23 | 2022-03-21+ | PCVX | PICKERING GRANT | CEO, Dir | S - Sale+OE | $24.83 | -22.0K | 703.9K | -3% | -$546.2K |
| DM | 2022-03-23 | 2022-03-21+ | PCVX | PICKERING GRANT | CEO, Dir | M - OptEx | $1.79 | +22.0K | 711.6K | +3% | +$39.4K |
| D | 2022-03-22 | 2022-03-18 | PCVX | GUGGENHIME ANDREW | Pres, CFO | S - Sale+OE | $26.13 | -3,100 | 40.6K | -7% | -$81.0K |
| D | 2022-03-22 | 2022-03-18 | PCVX | GUGGENHIME ANDREW | Pres, CFO | M - OptEx | $5.35 | +3,100 | 43.7K | +8% | +$16.6K |
| I | 2022-03-15 | 2022-03-11 | PCVX | Fairman Jeff | VP, Research | S - Sale | $25.50 | -10.0K | 331.2K | -3% | -$255.0K |
| 2022-03-14 | 2022-03-10 | PCVX | Sauer Paul | SVP Process Dev, Manufacturing | S - Sale | $25.00 | -6,000 | 31.1K | -16% | -$150.0K | |
| D | 2022-03-04 | 2022-03-02 | PCVX | Fairman Jeff | VP, Research | A - Grant | $0.00 | +6,000 | 16.6K | +56% | $0 |
| D | 2022-03-04 | 2022-03-02 | PCVX | PICKERING GRANT | CEO, Dir | A - Grant | $0.00 | +71.9K | 703.9K | +11% | $0 |
| D | 2022-03-04 | 2022-03-02 | PCVX | Wassil Jim | COO | A - Grant | $0.00 | +25.0K | 42.9K | +139% | $0 |
| D | 2022-03-04 | 2022-03-02 | PCVX | GUGGENHIME ANDREW | Pres, CFO | A - Grant | $0.00 | +37.5K | 40.6K | +1,200% | $0 |
| D | 2022-03-04 | 2022-03-02 | PCVX | Sauer Paul | SVP Process Dev, Manufacturing | A - Grant | $0.00 | +10.0K | 37.1K | +37% | $0 |
| D | 2022-03-04 | 2022-03-02 | PCVX | Dhaliwal Harpreet S. | SVP Cml Mfg, Supply Chain | A - Grant | $0.00 | +17.5K | 17.5K | New | $0 |
| D | 2022-03-03 | 2022-03-01 | PCVX | GUGGENHIME ANDREW | Pres, CFO | M - OptEx | $5.35 | +6,200 | 9,325 | +198% | +$33.2K |
| D | 2022-03-03 | 2022-03-01 | PCVX | GUGGENHIME ANDREW | Pres, CFO | S - Sale+OE | $24.00 | -6,200 | 3,125 | -66% | -$148.8K |
| D | 2022-02-28 | 2022-02-24 | PCVX | Wassil Jim | COO | S - Sale+OE | $22.00 | -10.0K | 17.9K | -36% | -$220.0K |
| D | 2022-02-28 | 2022-02-24 | PCVX | Wassil Jim | COO | M - OptEx | $2.42 | +10.0K | 27.9K | +56% | +$24.2K |
| D | 2022-02-08 | 2021-12-20 | PCVX | Fairman Jeff | VP, Research | M - OptEx | $1.79 | +4,469 | 10.6K | +73% | +$8,000 |
| 2021-12-30 | 2021-12-29 | PCVX | Sauer Paul | SVP Process Dev, Manufacturing | S - Sale | $25.00 | -6,000 | 27.1K | -18% | -$150.0K | |
| DM | 2021-12-28 | 2021-12-27 | PCVX | Fairman Jeff | VP, Research | S - Sale+OE | $23.60 | -4,750 | 6,335 | -43% | -$112.1K |
| D | 2021-12-28 | 2021-12-27 | PCVX | Fairman Jeff | VP, Research | M - OptEx | $1.79 | +4,750 | 10.9K | +77% | +$8,502 |
| D | 2021-12-28 | 2021-12-23 | PCVX | GUGGENHIME ANDREW | Pres, CFO | M - OptEx | $5.35 | +3,100 | 6,225 | +99% | +$16.6K |
| D | 2021-12-28 | 2021-12-23 | PCVX | GUGGENHIME ANDREW | Pres, CFO | S - Sale+OE | $24.00 | -3,100 | 3,125 | -50% | -$74.4K |
| DM | 2021-12-28 | 2021-12-27 | PCVX | PICKERING GRANT | CEO, Dir | M - OptEx | $1.80 | +51.8K | 630.6K | +9% | +$93.0K |
| D | 2021-12-20 | 2021-12-16 | PCVX | Fairman Jeff | VP, Research | M - OptEx | $1.79 | +4,619 | 10.8K | +75% | +$8,268 |
| D | 2021-12-20 | 2021-12-16 | PCVX | Fairman Jeff | VP, Research | S - Sale+OE | $22.50 | -4,619 | 6,160 | -43% | -$103.9K |
| D | 2021-12-13 | 2021-12-09 | PCVX | Fairman Jeff | VP, Research | S - Sale+OE | $22.50 | -131 | 6,160 | -2% | -$2,948 |
| D | 2021-12-13 | 2021-12-09 | PCVX | Fairman Jeff | VP, Research | M - OptEx | $1.79 | +131 | 6,291 | +2% | +$234.49 |
| DM | 2021-11-23 | 2021-11-19 | PCVX | PICKERING GRANT | CEO, Dir | S - Sale+OE | $23.45 | -15.0K | 580.3K | -3% | -$351.7K |
| D | 2021-11-23 | 2021-11-19 | PCVX | PICKERING GRANT | CEO, Dir | M - OptEx | $1.79 | +15.0K | 595.3K | +3% | +$26.9K |
| DM | 2021-11-22 | 2021-11-18 | PCVX | GUGGENHIME ANDREW | Pres, CFO | S - Sale+OE | $24.53 | -3,100 | 3,240 | -49% | -$76.0K |
| D | 2021-11-22 | 2021-11-18 | PCVX | GUGGENHIME ANDREW | Pres, CFO | M - OptEx | $5.35 | +3,100 | 6,225 | +99% | +$16.6K |
| 2021-11-03 | 2021-11-01 | PCVX | Sauer Paul | SVP Process Dev, Manufacturing | S - Sale | $25.00 | -3,000 | 33.1K | -8% | -$75.0K | |
| D | 2021-10-28 | 2021-10-26 | PCVX | Fairman Jeff | VP, Research | M - OptEx | $1.79 | +4,750 | 9,894 | +92% | +$8,502 |
| D | 2021-10-28 | 2021-10-26 | PCVX | Fairman Jeff | VP, Research | S - Sale+OE | $22.69 | -4,750 | 5,144 | -48% | -$107.8K |
| D | 2021-10-22 | 2021-10-20 | PCVX | PICKERING GRANT | CEO, Dir | M - OptEx | $1.79 | +15.0K | 595.3K | +3% | +$26.9K |
| DM | 2021-10-22 | 2021-10-20 | PCVX | PICKERING GRANT | CEO, Dir | S - Sale+OE | $22.58 | -15.0K | 581.3K | -3% | -$338.8K |
| DM | 2021-09-29 | 2021-09-27 | PCVX | Fairman Jeff | VP, Research | S - Sale+OE | $26.17 | -4,750 | 5,283 | -47% | -$124.3K |
| D | 2021-09-29 | 2021-09-27 | PCVX | Fairman Jeff | VP, Research | M - OptEx | $1.79 | +4,750 | 9,894 | +92% | +$8,502 |
| 2021-09-24 | 2021-09-22 | PCVX | Sauer Paul | SVP Process Dev, Manufacturing | S - Sale | $25.20 | -5,307 | 36.1K | -13% | -$133.7K | |
| DM | 2021-09-23 | 2021-09-21+ | PCVX | PICKERING GRANT | CEO, Dir | M - OptEx | $1.79 | +15.0K | 584.4K | +3% | +$26.9K |
| DM | 2021-09-23 | 2021-09-21+ | PCVX | PICKERING GRANT | CEO, Dir | S - Sale+OE | $25.21 | -15.0K | 580.3K | -3% | -$378.2K |
| D | 2021-08-30 | 2021-08-26 | PCVX | Fairman Jeff | VP, Research | M - OptEx | $1.79 | +4,750 | 9,894 | +92% | +$8,502 |
| DM | 2021-08-30 | 2021-08-26 | PCVX | Fairman Jeff | VP, Research | S - Sale+OE | $25.38 | -4,750 | 8,362 | -36% | -$120.5K |
| DM | 2021-08-25 | 2021-08-23 | PCVX | PICKERING GRANT | CEO, Dir | S - Sale+OE | $22.73 | -13.7K | 580.3K | -2% | -$310.7K |
| D | 2021-08-25 | 2021-08-23 | PCVX | PICKERING GRANT | CEO, Dir | M - OptEx | $1.79 | +13.7K | 593.9K | +2% | +$24.5K |
| D | 2021-08-20 | 2021-08-19 | PCVX | PICKERING GRANT | CEO, Dir | S - Sale+OE | $22.40 | -1,331 | 580.3K | -0.2% | -$29.8K |
| D | 2021-08-20 | 2021-08-19 | PCVX | PICKERING GRANT | CEO, Dir | M - OptEx | $1.79 | +1,331 | 581.6K | +0.2% | +$2,382 |
| D | 2021-08-18 | 2021-08-16 | PCVX | Wright-Mitchell Jane | GC | S - Sale+OE | $26.00 | -2,500 | 3,125 | -44% | -$65.0K |
| D | 2021-08-18 | 2021-08-16 | PCVX | Wright-Mitchell Jane | GC | M - OptEx | $2.03 | +2,500 | 5,625 | +80% | +$5,075 |
| D | 2021-08-16 | 2021-08-12 | PCVX | Wright-Mitchell Jane | GC | M - OptEx | $2.03 | +10.0K | 13.1K | +320% | +$20.3K |
| D | 2021-08-16 | 2021-08-12 | PCVX | Wright-Mitchell Jane | GC | S - Sale+OE | $26.00 | -10.0K | 3,125 | -76% | -$260.0K |
| D | 2021-07-28 | 2021-07-26 | PCVX | Fairman Jeff | VP, Research | S - Sale+OE | $22.70 | -4,750 | 5,144 | -48% | -$107.8K |
| D | 2021-07-28 | 2021-07-26 | PCVX | Fairman Jeff | VP, Research | M - OptEx | $1.79 | +4,750 | 9,894 | +92% | +$8,502 |
| D | 2021-07-22 | 2021-07-20 | PCVX | PICKERING GRANT | CEO, Dir | M - OptEx | $1.79 | +15.0K | 595.3K | +3% | +$26.9K |
| D | 2021-07-22 | 2021-07-20 | PCVX | PICKERING GRANT | CEO, Dir | S - Sale+OE | $22.85 | -15.0K | 580.3K | -3% | -$342.8K |
Purchase Sale Sale after option exercise All abbreviations